The European Circular Bioeconomy Fund invests EUR 18 million in Aphea.Bio to advance sustainable agricultural solutions through innovative biostimulants and biofungicides.

Information on the Target

Aphea.Bio, based in Gent, Belgium, is at the forefront of developing innovative agro-biological solutions utilizing natural microorganisms. The company focuses on harnessing the potential of the plant microbiome to create biostimulants that minimize fertilizer usage and biofungicides that combat fungal diseases prevalent in major row crops like maize and wheat. Their approach is centered around tapping into the vast natural biodiversity of microorganisms, enabling them to identify and cultivate novel biological products.

With a sophisticated discovery platform that integrates proprietary technologies, Aphea.Bio meticulously analyzes a plethora of microbial collections to isolate beneficial strains. This dedication to innovation positions them uniquely within the agricultural sector, aiming to advance both sustainability and efficiency in crop management.

Industry Overview in Belgium

Belgium is recognized as a significant player within the European agricultural biotechnology industry, which is experiencing rapid growth driven by increasing consumer demand for sustainable and environmentally friendly farming practices. T